News & Events

News & Events

Press Releases

Nov 08, 2018
Tricida Announces Third Quarter 2018 Financial Results
Advanced Key Initiatives for NDA Submission Launched Non-Branded Metabolic Acidosis Disease Awareness Campaign Presented TRCA-301 Pivotal Trial Results at ASN Kidney Week Late-Breaker Session Webcast Today at 5:00 pm ET SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Nov. 8, 2018-- Tricida, Inc.
Jun 27, 2018
Tricida Announces Pricing of Initial Public Offering
SOUTH SAN FRANCISCO, Calif.--( BUSINESS WIRE )--Tricida, Inc., a pharmaceutical company focused on the development and commercialization of TRC101, a non-absorbed, orally-dosed polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease, today announced the pricing of
Jun 04, 2018
Tricida Announces Kathryn Falberg Joins Board of Directors
SOUTH SAN FRANCISCO, Calif., June 4, 2018, (Business Wire) Tricida, Inc. announced today that Kathryn Falberg has joined its Board of Directors and has been named the chairperson of its Audit Committee. Ms. Falberg is a seasoned pharmaceutical industry executive with extensive leadership and

Corporate Presentation

Upcoming Events

There are no upcoming events available at this time.